首站-论文投稿智能助手
典型文献
Foe and friend in the COVID-19-associated acute kidney injury:an insight on intrarenal renin-angiotensin system
文献摘要:
Since the first reported case in December of 2019,the coronavirus disease 2019(COVID-19)has became an inter-national public health emergency.So far,there are more than 228,206,384 confirmed cases including 4,687,066 deaths.Kidney with high expression of angiotensin-converting enzyme 2(ACE2)is one of the extrapulmonary target organs affected in patients with COVID-19.Acute kidney injury(AKI)is one of the independent risk factors for the death of COVID-19 patients.The imbalance between ACE2-Ang(1-7)-MasR and ACE-Ang Ⅱ-AT1R axis in the kidney may contribute to COVID-19-associated AKI.Although series of research have shown the inconsistent effects of multiple common RAS inhibitors on ACE2 expression and enzyme activity,most of the retrospective cohort studies indicated the safety and protective effects of ACEI/ARB in COVID-19 patients.This review article highlights the current knowledge on the possible involvement of intrarenal RAS in COVID-19-associated AKI with a primary focus on the opposing effects of ACE2-Ang(1-7)-MasR and ACE-Ang Ⅱ-AT1R signaling in the kidney.Human re-combinant soluble ACE2 or ACE2 variants with preserved ACE2-enzymatic activity may be the best options to improve COVID-19-associated AKI.
文献关键词:
作者姓名:
Chuanming Xu;Yanting Chen;Jun Yu
作者机构:
Translational Medicine Centre,Jiangxi University of Chinese Medicine,Nanchang,330002,China;Institute of Hypertension,Sun Yat-sen University School of Medicine,Guangzhou 510080,China;Center for Metabolic Disease Research and Department of Physiology,Lewis Katz School of Medicine,Temple University,Philadelphia,PA 19140,USA
引用格式:
[1]Chuanming Xu;Yanting Chen;Jun Yu-.Foe and friend in the COVID-19-associated acute kidney injury:an insight on intrarenal renin-angiotensin system)[J].生物化学与生物物理学报(英文版),2022(01):1-11
A类:
Foe,combinant
B类:
friend,associated,acute,kidney,injury,insight,intrarenal,renin,angiotensin,system,Since,first,reported,December,coronavirus,disease,has,became,inter,national,public,health,emergency,So,far,there,more,than,confirmed,cases,including,deaths,Kidney,expression,converting,enzyme,ACE2,one,extrapulmonary,target,organs,affected,patients,Acute,AKI,independent,risk,factors,imbalance,between,Ang,MasR,AT1R,axis,may,contribute,Although,series,research,have,shown,inconsistent,effects,multiple,common,RAS,inhibitors,activity,most,retrospective,cohort,studies,indicated,safety,protective,ACEI,ARB,This,review,article,highlights,current,knowledge,possible,involvement,primary,focus,opposing,signaling,Human,soluble,variants,preserved,enzymatic,best,options,improve
AB值:
0.564696
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
SARS-CoV-2 involvement in central nervous system tissue damage
Muhammad Ali Haidar;Zaynab Shakkour;Mohammad Amine Reslan;Nadine Al-Haj;Perla Chamoun;Karl Habashy;Hasan Kaafarani;Shima Shahjouei;Sarah H.Farran;Abdullah Shaito;Esber S.Saba;Bassam Badran;Mirna Sabra;Firas Kobeissy;Maya Bizri-Department of Biochemistry and Molecular Genetics,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Faculty of Health Sciences,University of Balamand,Beirut,Lebanon;Faculty of Medicine,University of Balamand,Koura,Lebanon;Faculty of Science,Lebanese University,Baabda,Lebanon;Program for Neurotrauma,Neuroproteomics&Biomarkers Research,Departments of Emergency Medicine,University of Florida,Gainesville,FL,USA;Department of Pathology and Laboratory Medicine,American University of Beirut Medical Center,Beirut,Lebanon;Biomedical Research Center,Qatar University,Doha,Qatar;Department of Experimental Pathology,Immunology and Microbiology,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Laboratory of Cancer Biology and Molecular Immunology,Faculty of Sciences I,Lebanese University,Hadath,Beirut,Lebanon;Faculty of Medicine,Lebanese University,Neuroscience Research Center(NRC),Beirut,Lebanon;Neuroscience Institute,Neurology Department,Geisinger Health System,PA,USA;Department of Psychiatry,American University of Beirut,Beirut,Lebanon
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Potential medicinal plants involved in inhibiting 3CLpro activity:A practical alternate approach to combating COVID-19
Fan Yang;Xiao-lan Jiang;Akash Tariq;Sehrish Sadia;Zeeshan Ahmed;Jordi Sardans;Muhammad Aleem;Riaz Ullah;Rainer W.Bussmann-The Medical Center of General Practice,Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu 610041,Sichuan Province,China;Xinjiang Institute of Ecology and Geography,Chinese Academy of Sciences,Urumqi 830041,Xinjiang Uygur Autonomous Region,China;Department of Biological Sciences,University of Veterinary and Animal Sciences,Ravi Campus,Pattoki 55300,Pakistan;Consejo Superior de Investigaciones Científicas,Global Ecology Unit,Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Cientificas-Universitat Autònoma de Barcelona,Bellaterra,Barcelona 08193,Catalonia,Spain;Centre for Ecological Research and Forestry Applications,Cerdanyola del Vallès 08193,Catalonia,Spain;Department of Pharmacognosy,College of Pharmacy,King Saud University,Riyadh 11451,Saudi Arabia;Department of Ethnobotany,Institute of Botany,Ilia State University,Tbilisi 0105,Georgia
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension
Huai-yu Wang;Suyuan Peng;Zhanghui Ye;Pengfei Li;Qing Li;Xuanyu Shi;Rui Zeng;Ying Yao;Fan He;Junhua Li;Liu Liu;Shuwang Ge;Xianjun Ke;Zhibin Zhou;Gang Xu;Ming-hui Zhao;Haibo Wang;Luxia Zhang;Erdan Dong-National Institute of Health Data Science at Peking University,Beijing 100191,China;Peking University Advanced Institute of Information Technology,Hangzhou 311215,China;Department of Nephrology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Clinical Nutrition,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Taikang Tongji(Wuhan)Hospital,Wuhan 430050,China;Renal Division,Department of Medicine,Peking University First Hospital,Peking University Institute of Nephrology,Beijing 100034,China;Peking-Tsinghua Center for Life Sciences,Beijing 100871,China;First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital;Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Ministry of Health;Key Laboratory of Molecular Cardiovascular Sciences,Ministry of Education;Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B:a multi-center retrospective cohort study
Jing Wang;Zequn Lu;Meng Jin;Ying Wang;Kunming Tian;Jun Xiao;Yimin Cai;Yanan Wang;Xu Zhang;Tao Chen;Zhi Yao;Chunguang Yang;Renli Deng;Qiang Zhong;Xiongbo Deng;Xin Chen;Xiang-ping Yang;Gonghong Wei;Zhihua Wang;Jianbo Tian;Xiao-ping Chen-Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Epidemiology and Biostatistics,Key Laboratory for Environment and Health,School of Public Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Respiratory and Critical Care Medicine,Renmin Hospital of Wuhan University,Wuhan 430060,China;Department of Virology,Wuhan Centers for Disease Prevention and Control,Wuhan 430024,China;Institute of Reproductive Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;School of Nursing,Zunyi Medical University,Zunyi 563099,China;Key Laboratory of Environment and Health,Ministry of Education&Ministry of Environmental Protection,and State Key Laboratory of Environmental Health(Incubating),School of Public Health,Tongji Medical College,Huazhong University of Science and Technology Wuhan 430030,China;Department and Institute of Infectious Disease,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Respirology and Tuberculosis Specialty,Wuhan Pulmonary Hospital,Wuhan 430030,China;The Fifth Affiliated(Zhuhai)Hospital of Zunyi Medical University,Zhuhai 519199,China;Department of Critical Care Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Wuhan Jinyintan Hospital,Wuhan 430048,China;Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Immunology,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Biocenter Oulu,Faculty of Biochemistry and Molecular Medicine,University of Oulu,Oulu 90014,Finland;Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。